XGX Pharma ApS — Credit Rating and Financial Key Figures

XGX Pharma ApS (CVR number: 32289290) is a company from KØBENHAVN. The company recorded a gross profit of 16 mDKK in 2024. The operating profit was 6536.7 kDKK, while net earnings were 4453.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 18.9 %, which can be considered excellent and Return on Equity (ROE) was 27 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 48 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. XGX Pharma ApS's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.